News
Better High-Yield Dividend Stock to Buy Now: AT&T vs. Altria Group
Investors looking for high-yield dividend stocks that can raise their payouts further may want to look at the telecommunications and tobacco industries.
Shares of telecommunications giant AT&T
Is It Too Late to Buy Pfizer Stock?
Are Pfizer's (NYSE: PFE) best days behind it? If the stock's critics are to be believed, the answer is an emphatic "yes, obviously," with issues like its recent stint of unprofitability and a
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
Few industries are more essential than healthcare. That makes it an excellent place to look for stocks that can perform well over extended periods since the basic services they offer are unlikely to
Is It Too Late to Buy Novavax Stock?
Novavax (NASDAQ: NVAX) stock is suddenly a buy again this year, with its stock price more than tripling since the start of 2024. Some positive developments in recent months, including a deal with
3 Reasons to Buy Rivian Now
There are plenty of reasons to be pessimistic about the electric vehicle (EV) industry now, but that could also make it a perfect time to buy in while stock prices are depressed. To be fair, not
Trust for the National Mall and Humana Bring Pickleball Back to the National Mall for Second Year with an Expanded Footprint
The Trust for the National Mall, Humana (NYSE: HUM), and the Humana Foundation announced today that the National Mall of Pickleball is returning to America’s Front Yard, the National Mall, for a
University of Louisville Study Outlines Humana’s Economic and Community Impact on Kentucky
The University of Louisville’s College of Business recently released the results of a study that evaluated Humana’s economic and community impact on Kentucky.
This press release features
3 High-Yielding Dividend Stocks That Pay More Than Four Times the S&P 500 Average
If you want a good dividend, you can aim much higher than the 1.4% yield that the S&P 500 averages. In some cases, you can earn a lot more than the average -- without even having to take on much
2 Healthcare Stocks to Buy Hand Over Fist in June
We're almost halfway through the year, and so far, it's been a pretty solid one for equity markets. It's as good a time as any to review one's portfolio and potentially consider putting more money
EQS-News: Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb
Why Axsome Therapeutics Stock Is Sinking Today
Shares of Axsome Therapeutics (NASDAQ: AXSM) were sinking 6.8% lower as of 11:19 a.m. ET on Tuesday. The decline came after Culper Research announced a short position in the biotech stock before the
Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?
Johnson & Johnson reigned as the largest healthcare company in the world for years. UnitedHealth Group also took a turn at the top. However, the title now belongs to Eli Lilly (NYSE: LLY) -- and it
Billionaires Are Buying These 2 Ultra-High-Yield Dividend Stocks Hand Over Fist. Are They Smart Buys for Your Portfolio?
Billionaire investors generally don't necessarily need dividend income to make ends meet. They buy dividend-paying stocks because they know that companies committed to returning a portion of
EQS-News: Evotec SE: Results of the Annual General Meeting 2024
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
Viking Therapeutics (NASDAQ: VKTX) and Madrigal Pharmaceuticals (NASDAQ: MDGL) are highly prominent biotech companies that have a lot in common. Both focus on treating metabolic illnesses like liver
This High-Flying Stock Just Announced More Good News: Time to Buy?
The biotech industry features many prominent companies that command plenty of attention on the market. And since the year started, few biotechs have made more noise than Viking Therapeutics (NASDAQ:
What Is the Dividend Payout for UnitedHealth Group Stock?
Healthcare giants sometimes pay decent dividend distributions, and UnitedHealth Group (NYSE: UNH) certainly falls into that category. In the wake of difficult circumstances, however, investors might
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
Cathie Wood is known for two things: picking out innovators that will go on to score a win over the long run, and getting in on these stocks at a great price. The founder and chief executive officer
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock.
Generating dividend income can be an excellent way to put your cash to work. It can provide you with an extra stream of cash flow to diversify your income and help you pay bills, or perhaps fund a
These 2 Words Are Why Intellia Therapeutics Could Be a Smart Buy Right Now
On June 2, Intellia Therapeutics' (NASDAQ: NTLA) CEO John Leonard remarked on the biotech's progress with one of its early-stage clinical programs called NTLA-2002, uttering two very important words
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Not all dividend stocks are equal. Some are safer than others. Some have much higher dividend yields than others. When a stock offers both advantages, it's usually a keeper.
Three Motley Fool
Is Geron Stock a Buy Following Its First New Drug Approval?
Shares of Geron (NASDAQ: GERN) finished the week ended June 7 about 32% higher. The market was reacting to news the company's investors had been waiting to hear for decades.
On June 6, the U.S. Food
U.S. Rep. Thomas Kean Jr. Just Bought Illumina Stock and Sold Nike Stock. Should You Do the Same?
On April 19, U.S. Rep. Thomas Kean Jr., R-N.J., bought shares of Illumina (NASDAQ: ILMN) and sold shares of Nike (NYSE: NKE), according to a May 31 filing. Although it's unclear exactly how many
What's Wrong With Oil and Gas Stocks Right Now?
Oil prices dropped like a rock this week and that hit oil-related stocks hard. Ironically, it was OPEC+ extending production cuts that sent oil lower, which seems a little backward.
According to
2 Dividend Stocks Billionaires Are Buying: Should You?
Many billionaires are active on Wall Street and largely built their wealth that way. So, paying attention to their moves and the stocks they invest in can teach us a lot. Of course, blindly